We are live on ! Find out more
ZIVO

Zivo Bioscience, Inc. Common Stock
ZIVO

Delisted

ZIVO was delisted on the 24th of November, 2023.

Back to rankings

12 hedge funds and large institutions have $829K invested in Zivo Bioscience, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more capital invested

Capital invested by funds: $195K → $829K (+$634K)

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

71% more funds holding

Funds holding: 7 → 12 (+5)

Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
+$165K
2
Jane Street
Jane Street
New York
+$153K
3
Two Sigma Investments
Two Sigma Investments
New York
+$114K
4
TSS
Two Sigma Securities
New York
+$110K
5
TRCT
Tower Research Capital (TRC)
New York
+$40.7K

Top Sellers

Rank Fund Capital Flow
1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$149K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Credit Suisse
Switzerland
$206K +$165K +7,522 New
Jane Street
2
Jane Street
New York
$191K +$153K +6,989 New
Two Sigma Investments
3
Two Sigma Investments
New York
$143K +$114K +5,228 New
TSS
4
Two Sigma Securities
New York
$138K +$110K +5,043 New
TRCT
5
Tower Research Capital (TRC)
New York
$51K +$40.7K +1,863 New
VCA
6
Verdence Capital Advisors
Maryland
$46K +$36.5K +1,667 New
Wells Fargo
7
Wells Fargo
California
$30K +$153 +7 +0.6%
UBS Group
8
UBS Group
Switzerland
$10K +$7.7K +352 New
BC
9
Bartlett & Co
Ohio
$5K – – –
BCWM
10
Bartlett & Co Wealth Management
Ohio
$4.56K – – –
PNC Financial Services Group
11
PNC Financial Services Group
Pennsylvania
$3K – – –
Morgan Stanley
12
Morgan Stanley
New York
$1K – – –
Commonwealth Equity Services
13
Commonwealth Equity Services
Massachusetts
– -$149K -5,273 Closed

ZIVO Hedge Fund Activity: Q3 2021 in Review

12 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q3 2021, worth a combined $829K — up 325% from $195K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ZIVO positions and 2 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Credit Suisse, opening a new position worth an estimated $165K. The largest seller was Commonwealth Equity Services, exiting entirely with an estimated $149K sold.

  • 12 institutional investors held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q3 2021, up from 7 in Q2 2021.
  • Funds reported $829K of Zivo Bioscience, Inc. Common Stock stock for Q3 2021, up 325% quarter-over-quarter.
  • 7 funds opened new Zivo Bioscience, Inc. Common Stock positions in Q3 2021 and 2 closed out, a net change of +5 holders.
  • The largest Zivo Bioscience, Inc. Common Stock buyer in Q3 2021 was Credit Suisse, an estimated $165K added.
  • The largest Zivo Bioscience, Inc. Common Stock seller in Q3 2021 was Commonwealth Equity Services, an estimated $149K sold.

Based on aggregated 13F filings for Q3 2021.